Product Information
SEROQUEL XR 150 MG TABLET is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $14.1432 per EA under NDC 00310028160. Its NADAC has been published 406 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the quetiapine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310028160
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
10/22/2025
Active Ingredients
QUETIAPINE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA022047On Market Since
2/1/2009
Pharmacological Classes
Price Statistics
The NADAC for SEROQUEL XR 150 MG TABLET has been published 406 times since Nov 28, 2013, and over the history we have for it it has risen 27.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.1432 per EA |
|---|---|
| All-time high | $14.2512 (Sep 13, 2017) |
| All-time low | $11.1343 (Nov 28, 2013) |
| 52-week high | $14.2108 |
| 52-week low | $14.1429 |
| Median price | $14.1385 |
| Average price | $13.7605 |
| Largest weekly change | +10.0% (Jan 8, 2014) |
| Weeks tracked | 406 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the quetiapine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of SEROQUEL XR 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SEROQUEL XR 150 MG TABLET, manufactured by AstraZeneca Pharmaceuticals LP, is $14.1432 per EA (NDC 00310028160), effective Apr 1, 2026.
How has the price of SEROQUEL XR 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for SEROQUEL XR 150 MG TABLET has risen 27.0%. It has been tracked across 406 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SEROQUEL XR 150 MG TABLET?
Since Nov 28, 2013, the NADAC for SEROQUEL XR 150 MG TABLET has ranged from a low of $11.1343 (Nov 28, 2013) to a high of $14.2512 (Sep 13, 2017), with a median of $14.1385 per EA.
Are there cheaper alternatives to SEROQUEL XR 150 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of SEROQUEL XR 150 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures SEROQUEL XR 150 MG TABLET?
SEROQUEL XR 150 MG TABLET (NDC 00310028160) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.
Related Drugs
Same classification